Yushen Wu

Chongqing Key Laboratory Of Molecular Oncology And Epigenetics
Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

AEBP1 drives fibroblast-mediated T cell dysfunction in tumors.

AEBP1 drives fibroblast-mediated T cell dysfunction in tumors.

Journal: Nature communications

Published: August 22, 2024

Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy.

Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy.

Journal: The Journal of clinical investigation

Published: May 29, 2024

Blocking WNT7A Enhances MHC-I Antigen Presentation and Enhances the Effectiveness of Immune Checkpoint Blockade Therapy.

Blocking WNT7A Enhances MHC-I Antigen Presentation and Enhances the Effectiveness of Immune Checkpoint Blockade Therapy.

Journal: Cancer immunology research

Published: May 20, 2024

Loss of RPN1 promotes antitumor immunity via PD-L1 checkpoint blockade in triple-negative breast cancer - experimental studies.

Loss of RPN1 promotes antitumor immunity via PD-L1 checkpoint blockade in triple-negative breast cancer - experimental studies.

Journal: International journal of surgery (London, England)

Published: April 22, 2024

IGJ suppresses breast cancer growth and metastasis by inhibiting EMT via the NF‑κB signaling pathway.

IGJ suppresses breast cancer growth and metastasis by inhibiting EMT via the NF‑κB signaling pathway.

Journal: International journal of oncology

Published: April 04, 2023

ZDHHC22-mediated mTOR palmitoylation restrains breast cancer growth and endocrine therapy resistance.

ZDHHC22-mediated mTOR palmitoylation restrains breast cancer growth and endocrine therapy resistance.

Journal: International journal of biological sciences

Published: December 31, 2021

FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts.

FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts.

Journal: Theranostics

Published: November 12, 2021

ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.

ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.

Journal: Frontiers in immunology

Published: January 24, 2021

The Prognostic Value of Circulating Soluble Programmed Death Ligand-1 in Cancers: A Meta-Analysis.

The Prognostic Value of Circulating Soluble Programmed Death Ligand-1 in Cancers: A Meta-Analysis.

Journal: Frontiers in oncology

Published: November 07, 2020

Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis.

Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis.

Journal: Cancer cell international

Published: July 13, 2020

Risk factors associated with suicide among hepatocellular carcinoma patients: A surveillance, epidemiology, and end results analysis.

Risk factors associated with suicide among hepatocellular carcinoma patients: A surveillance, epidemiology, and end results analysis.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: June 07, 2020

CircEHMT1 inhibits metastatic potential of breast cancer cells by modulating miR-1233-3p/KLF4/MMP2 axis.

CircEHMT1 inhibits metastatic potential of breast cancer cells by modulating miR-1233-3p/KLF4/MMP2 axis.

Journal: Biochemical and biophysical research communications

Published: March 09, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026